MIAOZHANGMIAO ZHANG11867ZHANG, MIAOAssistant Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonGenitourinary Medical OncologyMD AndersonLOUIS LPISTERSLOUIS L PISTERS8619PISTERS, LOUIS LProfessorASHISHKAMATASHISH KAMAT8961KAMAT, ASHISHProfessorJIANJUNGAOJIANJUN GAO9668GAO, JIANJUNAssistant ProfessorBOGDAN ACZERNIAKBOGDAN A CZERNIAK8446CZERNIAK, BOGDAN AProfessorPHEROZETAMBOLIPHEROZE TAMBOLI8780TAMBOLI, PHEROZEProfessorCHARLES CHUANHAIGUOCHARLES CHUANHAI GUO9349GUO, CHARLES CHUANHAIAssociate ProfessorCHRISTOPHER JLOGOTHETISCHRISTOPHER J LOGOTHETIS8480LOGOTHETIS, CHRISTOPHER JProfessorSURENAMATINSURENA MATIN9030MATIN, SURENAProfessorCOLIN PDINNEYCOLIN P DINNEY8624DINNEY, COLIN PProfessor74Professor10Assistant Professor14Associate Professor1515 Holcombe BlvdHouston77030-4009TX0.5843010.0146402136research areas0.7668570.034136268coauthor of28.78724.4116760similar to1135selected publicationsAuthorship 848725Authorship 851258Authorship 858816Authorship 859190Authorship 863002Authorship 865052Authorship 867559BJU InternationalMetastases to the kidney. BJU International. Metastases to the kidneyOncotargetIntratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis. Oncotarget. 7:86280-86289.Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testisClinical Genitourinary CancerProlonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation. Clinical Genitourinary Cancer. Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous DifferentiationHuman PathologyRenal cell carcinoma metastatic to the ovary or fallopian tube. Human Pathology. 51:96-102.Renal cell carcinoma metastatic to the ovary or fallopian tubeHuman PathologySecondary malignancies diagnosed using kidney needle core biopsies. Human Pathology. 52:55-60.Secondary malignancies diagnosed using kidney needle core biopsiesHuman PathologyAdenoid cystic carcinoma of the urethra/Cowper's gland with concurrent high-grade prostatic adenocarcinoma. Human Pathology. 58:138-144.Adenoid cystic carcinoma of the urethra/Cowper's gland with concurrent high-grade prostatic adenocarcinomaEBioMedicineMeta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use. EBioMedicine. 12:105-117.Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Usetrue1ProfessorProfessorD002030Anatomy880.989339Bulbourethral GlandsD009378Disorders2915510.742893Neoplasms, Multiple PrimaryD011471Disorders75057370.293776Prostatic NeoplasmsD014523Disorders37600.954031Urethral NeoplasmsAuthorship 9077221Authorship 9085115Authorship 9107815Authorship 9111965Authorship 9116072Authorship 9127352Authorship 9169322Authorship 9245783Authorship 929912226053895Zhou C, Urbauer DL, Fellman BM, Tamboli P, Zhang M, Matin SF, Wood CG, Karam JABJU internationalMetastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre. BJU Int. 2016 May; 117(5):775-82.BJU Int2015-07-05T00:00:002015Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre.27067787Liang L, Huang H, Dadhania V, Zhang J, Zhang M, Liu JHuman pathologyRenal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases. Hum Pathol. 2016 May; 51:96-102.Hum Pathol2016-01-07T00:00:002016Renal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases.27554206Zhang M, Pettaway C, Vikram R, Tamboli PHuman pathologyAdenoid cystic carcinoma of the urethra/Cowper's gland with concurrent high-grade prostatic adenocarcinoma: a detailed clinicopathologic case report and review of the literature. Hum Pathol. 2016 12; 58:138-144.Hum Pathol2016-08-20T00:00:002016Adenoid cystic carcinoma of the urethra/Cowper's gland with concurrent high-grade prostatic adenocarcinoma: a detailed clinicopathologic case report and review of the literature.26980018Huang H, Tamboli P, Karam JA, Vikram R, Zhang MHuman pathologySecondary malignancies diagnosed using kidney needle core biopsies: a clinical and pathological study of 75 cases. Hum Pathol. 2016 06; 52:55-60.Hum Pathol2016-02-01T00:00:002016Secondary malignancies diagnosed using kidney needle core biopsies: a clinical and pathological study of 75 cases.27692813Msaouel P, Zhang M, Tu SMClinical genitourinary cancerProlonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case Report. Clin Genitourin Cancer. 2017 02; 15(1):e73-e77.Clin Genitourin Cancer2016-09-07T00:00:002016Prolonged Remission of Upper Urinary Tract Urothelial Carcinoma With Prominent Choriocarcinomatous Differentiation: A Case Report.27612592Dadhania V, Zhang M, Zhang L, Bondaruk J, Majewski T, Siefker-Radtke A, Guo CC, Dinney C, Cogdell DE, Zhang S, Lee S, Lee JG, Weinstein JN, Baggerly K, McConkey D, Czerniak BEBioMedicineMeta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use. EBioMedicine. 2016 Oct; 12:105-117.EBioMedicine2016-08-25T00:00:002016Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use.29807831Chahoud J, Zhang M, Pisters LL, Lin SC, Lin SH, Tu SMClinical genitourinary cancerIdentification of Glypican-3 (GPC3) Expression in a Lethal Subgroup of Refractory Cisplatin-Resistant Testicular Germ-Cell Tumors. Clin Genitourin Cancer. 2018 10; 16(5):325-327.Clin Genitourin Cancer2018-05-26T00:00:002018Identification of Glypican-3 (GPC3) Expression in a Lethal Subgroup of Refractory Cisplatin-Resistant Testicular Germ-Cell Tumors.29763719Wang G, Xiao L, Zhang M, Kamat AM, Siefker-Radtke A, Dinney CP, Czerniak B, Guo CCHuman pathologySmall cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases. Hum Pathol. 2018 09; 79:57-65.Hum Pathol2018-05-12T00:00:002018Small cell carcinoma of the urinary bladder: a clinicopathological and immunohistochemical analysis of 81 cases.30195014Li R, Zhang M, Duplisea JJ, Troncoso P, Ward JFUrologyDetection and Treatment of Primary Prostatic Melanoma. Urology. 2019 01; 123:16-19.Urology2018-09-05T00:00:002018Detection and Treatment of Primary Prostatic Melanoma.PathologyUrologyDepartment of UrologyUrologyBaylor College of MedicineSETHLERNERSETH LERNER29.70990600000000-95.402830000000002886LERNER, SETHProfessorAuthorship 941651530858546Sinha KM, Bagheri-Yarmand R, Lahiri S, Lu Y, Zhang M, Amra S, Rizvi Y, Wan X, Navone N, Ozpolat B, Logothetis C, Gagel RF, Huard JOncogeneOncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer. Oncogene. 2019 06; 38(25):5038-5049.Oncogene2019-03-11T00:00:002019Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer.Authorship 9465411231067463Guo CC, Majewski T, Zhang L, Yao H, Bondaruk J, Wang Y, Zhang S, Wang Z, Lee JG, Lee S, Cogdell D, Zhang M, Wei P, Grossman HB, Kamat A, Duplisea JJ, Ferguson JE, Huang H, Dadhania V, Gao J, Dinney C, Weinstein JN, Baggerly K, McConkey D, Czerniak BCell reportsDysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer. Cell Rep. 2019 05 07; 27(6):1781-1793.e4.Cell Rep2019-05-07T00:00:002019Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer.D062005Procedures1041340.910712Biopsy, Large-Core NeedleAuthorship 948812431175351Gan Q, Joseph CT, Guo M, Zhang M, Sun X, Gong YAmerican journal of clinical pathologyUtility of NKX3.1 Immunostaining in the Detection of Metastatic Prostatic Carcinoma on Fine-Needle Aspiration Smears. Am J Clin Pathol. 2019 09 09; 152(4):495-501.Am J Clin Pathol2019-09-09T00:00:002019Utility of NKX3.1 Immunostaining in the Detection of Metastatic Prostatic Carcinoma on Fine-Needle Aspiration Smears.Authorship 975847231941830Corn PG, Zhang M, Nogueras-Gonzalez GM, Xiao L, Zurita AJ, Subudhi SK, Tu SM, Aparicio AM, Coarfa C, Rajapakshe K, Huang S, Navone NM, Lin SH, Wang G, Ramachandran S, Titus MA, Panaretakis T, Gallick GE, Efstathiou E, Troncoso P, Logothetis CClinical cancer research : an official journal of the American Association for Cancer ResearchA Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Na?ve Metastatic Prostate Cancer. Clin Cancer Res. 2020 03 01; 26(5):990-999.Clin Cancer Res2020-01-15T00:00:002020A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Na?ve Metastatic Prostate Cancer.Authorship 977914232055486Siddiqui BA, Zhang M, Pisters LL, Tu SMTranslational andrology and urologySystemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment. Transl Androl Urol. 2020 Jan; 9(Suppl 1):S56-S65.Transl Androl Urol2020-01-01T00:00:002020Systemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment.Authorship 992035932546765Guo CC, Bondaruk J, Yao H, Wang Z, Zhang L, Lee S, Lee JG, Cogdell D, Zhang M, Yang G, Dadhania V, Choi W, Wei P, Gao J, Theodorescu D, Logothetis C, Dinney C, Kimmel M, Weinstein JN, McConkey DJ, Czerniak BScientific reportsAssessment of Luminal and Basal Phenotypes in Bladder Cancer. Sci Rep. 2020 06 16; 10(1):9743.Sci Rep2020-06-16T00:00:002020Assessment of Luminal and Basal Phenotypes in Bladder Cancer.Authorship 10070011633327406Umbreit EC, Siddiqui BA, Hwang MJ, Joon AY, Maity T, Westerman ME, Merriman KW, Alhasson H, Uthup J, Guo T, Moore JA, Ward JF, Karam JA, Wood CG, Pisters LL, Zhang M, Tu SMCancersOrigin of Subsequent Malignant Neoplasms in Patients with History of Testicular Germ Cell Tumor. Cancers (Basel). 2020 Dec 14; 12(12).Cancers (Basel)2020-12-14T00:00:002020Origin of Subsequent Malignant Neoplasms in Patients with History of Testicular Germ Cell Tumor.Authorship 1015135333824525Ranasinghe W, Shapiro DD, Zhang M, Bathala T, Navone N, Thompson TC, Broom B, Aparicio A, Tu SM, Tang C, Davis JW, Pisters L, Chapin BFNature reviews. UrologyOptimizing the diagnosis and management of ductal prostate cancer. Nat Rev Urol. 2021 06; 18(6):337-358.Nat Rev Urol2021-04-06T00:00:002021Optimizing the diagnosis and management of ductal prostate cancer.Authorship 1028444234439162Tu SM, Zhang M, Wood CG, Pisters LLCancersStem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity. Cancers (Basel). 2021 Aug 09; 13(16).Cancers (Basel)2021-08-09T00:00:002021Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity.Authorship 10342991534789422Alhalabi O, Zhu Y, Hamza A, Qiao W, Lin Y, Wang RM, Shah AY, Campbell MT, Holla V, Kamat A, Wang WL, Wang J, Chen J, Meng J, Zhang M, Bondaruk J, Titus M, Genovese G, Czerniak BA, Shaw KR, Meric-Bernstam F, Guo CC, Logothetis CJ, Siefker-Radtke A, Msaouel P, Wang L, Liu J, Gao JEuropean urology oncologyIntegrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer. Eur Urol Oncol. 2023 04; 6(2):228-232.Eur Urol Oncol2021-11-14T00:00:002021Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer.Authorship 10380906Authorship 103910413Authorship 1040500935092681Daher M, Varghese J, Gruschkus SK, Jimenez C, Waguespack SG, Bedrose S, Altameemi L, Bazerbashi H, Naing A, Subaiah V, Campbell MT, Shah AY, Zhang M, Sheth RA, Karam JA, Wood CG, Perrier ND, Graham PH, Lee JE, Habra MAThe Journal of clinical endocrinology and metabolismTemporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center Experience. J Clin Endocrinol Metab. 2022 04 19; 107(5):1239-1246.J Clin Endocrinol Metab2022-04-19T00:00:002022Temporal Trends in Outcomes in Patients With Adrenocortical Carcinoma: A Multidisciplinary Referral-center Experience.35267435Moore JA, Slack RS, Lehner MJ, Campbell MT, Shah AY, Zhang M, Guo CC, Ward JF, Karam JA, Wood CG, Pisters LL, Tu SMCancersVery Late Recurrence in Germ Cell Tumor of the Testis: Lessons and Implications. Cancers (Basel). 2022 Feb 23; 14(5).Cancers (Basel)2022-02-23T00:00:002022Very Late Recurrence in Germ Cell Tumor of the Testis: Lessons and Implications.35076303Ranasinghe WKB, Troncoso P, Surasi DS, Ibarra Rovira JJ, Bhosale P, Szklaruk J, Kokorovic A, Wang X, Elsheshtawi M, Zhang M, Aparicio A, Chapin BF, Bathala TKRadiologyDefining Diagnostic Criteria for Prostatic Ductal Adenocarcinoma at Multiparametric MRI. Radiology. 2022 04; 303(1):110-118.Radiology2022-01-25T00:00:002022Defining Diagnostic Criteria for Prostatic Ductal Adenocarcinoma at Multiparametric MRI.Authorship 10433762335379845Alhalabi O, Chen J, Zhang Y, Lu Y, Wang Q, Ramachandran S, Tidwell RS, Han G, Yan X, Meng J, Wang R, Hoang AG, Wang WL, Song J, Lopez L, Andreev-Drakhlin A, Siefker-Radtke A, Zhang X, Benedict WF, Shah AY, Wang J, Msaouel P, Zhang M, Guo CC, Czerniak B, Behrens C, Soto L, Papadimitrakopoulou V, Lewis J, Rinsurongkawong W, Rinsurongkawong V, Lee J, Roth J, Swisher S, Wistuba I, Heymach J, Wang J, Campbell MT, Efstathiou E, Titus M, Logothetis CJ, Ho TH, Zhang J, Wang L, Gao JNature communicationsMTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers. Nat Commun. 2022 04 04; 13(1):1797.Nat Commun2022-04-04T00:00:002022MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers.Authorship 1044944535499784Shirali AS, Zagzag J, Chiang YJ, Huang H, Zhang M, Habra MA, Grubbs EG, Fisher SB, Perrier ND, Lee JE, Graham PHAnnals of surgical oncologyDifferences in Clinicopathologic Behavior of Oncocytic Adrenocortical Neoplasms and Conventional Adrenocortical Carcinomas. Ann Surg Oncol. 2022 Sep; 29(9):5555-5563.Ann Surg Oncol2022-04-30T00:00:002022Differences in Clinicopathologic Behavior of Oncocytic Adrenocortical Neoplasms and Conventional Adrenocortical Carcinomas.Authorship 10609884Authorship 1061158536100698Sakellakis MJ, Hahn AW, Ramachandran S, Zhang M, Hoang A, Song JH, Liu J, Wang F, Basu HS, Sheperd P, Wang X, Frigo DE, Lin SH, Panaretakis T, Zhang J, Navone N, Troncoso P, Logothetis CJ, Titus MAProstate cancer and prostatic diseasesCharacterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormones. Prostate Cancer Prostatic Dis. 2023 Dec; 26(4):751-758.Prostate Cancer Prostatic Dis2022-09-13T00:00:002022Characterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormones.36433823Jimenez C, Ma J, Roman Gonzalez A, Varghese J, Zhang M, Perrier N, Habra MA, Graham P, Waguespack SGThe Journal of clinical endocrinology and metabolismTNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma. J Clin Endocrinol Metab. 2023 04 13; 108(5):1132-1142.J Clin Endocrinol Metab2023-04-13T00:00:002023TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma.Authorship 10865181138200650Cho WC, Saade R, Nagarajan P, Aung PP, Milton DR, Marques-Piubelli ML, Hudgens C, Ledesma D, Nelson K, Ivan D, Zhang M, Torres-Cabala CA, Campbell M, Alhalabi O, Prieto VG, Wistuba II, Esmaeli B, Curry JLJournal of cutaneous pathologyNectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin. J Cutan Pathol. 2024 Jan 10.J Cutan Pathol2024-01-10T00:00:002024Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin.Authorship 10878231738262868Gregg JR, Magill R, Fang AM, Chapin BF, Davis JW, Adibi M, Ch?ry L, Papadopoulos J, Pettaway C, Pisters L, Ward JF, Hahn AW, Daniel CR, Bhaskaran J, Zhu K, Guerrero M, Zhang M, Troncoso PUrologic oncologyThe association of body mass index with tumor aggression among men undergoing radical prostatectomy. Urol Oncol. 2024 Apr; 42(4):116.e1-116.e7.Urol Oncol2024-01-22T00:00:002024The association of body mass index with tumor aggression among men undergoing radical prostatectomy.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professor